|Tested species reactivity||Human|
|Published species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Synthetic peptide corresponding to a region within amino acids 253 and 317 of RANKL (Uniprot ID#O14788)|
|Purification||Antigen affinity chromatography|
|Storage buffer||0.1M tris glycine, pH 7, with 10% glycerol|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin) (IHC (P))||1:100-1:1000|
|Western Blot (WB)||1:500-1:3000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Immunohistochemistry (IHC)||See 1 publications below|
PA5-21951 targets RANKL (CD254) in immunohistochemistry (paraffin) and Western blot applications and shows reactivity with Human samples.
The PA5-21951 immunogen is a synthetic peptide corresponding to a region within amino acids 253 and 317 of RANKL (Uniprot ID#O14788).
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Co-expression of CD44+/RANKL+ tumor cells in the carcinogenesis of oral squamous cell carcinoma.
PA5-21951 was used in immunohistochemistry and western blot to study the role of cells positive for both CD44 and RANKL in the carcinogenesis of oral squamous cell carcinoma
|Grimm M,Renz C,Munz A,Hoefert S,Krimmel M,Reinert S||Odontology (103:36)||2015|